Volume 51, Issue 2, Pages 366-374 (February 2007) Overall and Disease-Specific Survival of Patients with Screen-Detected Prostate Cancer in the European Randomized Study of Screening for Prostate Cancer, Section Rotterdam Stijn H de Vries, Renske Postma, René Raaijmakers, Stijn Roemeling, Suzie Otto, Harry J. de Koning, Fritz H. Schröder European Urology Volume 51, Issue 2, Pages 366-374 (February 2007) DOI: 10.1016/j.eururo.2006.07.052 Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 1 Flow chart for European Randomized Study of Screening for Prostate Cancer (ERSPC), section Rotterdam. Adapted from reference [5]. European Urology 2007 51, 366-374DOI: (10.1016/j.eururo.2006.07.052) Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 2 (A) Observed versus expected overall survival. (B) Comparison of disease-specific survival of the European Randomized Study of Screening for Prostate Cancer (ERSPC) prevalence screen cohort with the observed pCA-specific mortality of Dutch males diagnosed at the age of 60–74 yr during four different time periods [10]. European Urology 2007 51, 366-374DOI: (10.1016/j.eururo.2006.07.052) Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 3 Prostate cancer–specific survival of high-risk prostate cancer patients (n=261). European Urology 2007 51, 366-374DOI: (10.1016/j.eururo.2006.07.052) Copyright © 2006 European Association of Urology Terms and Conditions